Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

2.

The new human kallikrein gene family: implications in carcinogenesis.

Diamandis EP, Yousef GM, Luo LY, Magklara A, Obiezu CV.

Trends Endocrinol Metab. 2000 Mar;11(2):54-60. Review.

PMID:
10675891
3.

The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions.

Clements J, Hooper J, Dong Y, Harvey T.

Biol Chem. 2001 Jan;382(1):5-14. Review.

PMID:
11258672
5.
6.

Kallikrein-related peptidases.

Lundwall A, Brattsand M.

Cell Mol Life Sci. 2008 Jul;65(13):2019-38. doi: 10.1007/s00018-008-8024-3. Review.

PMID:
18344018
7.

The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers.

Clements JA, Willemsen NM, Myers SA, Dong Y.

Crit Rev Clin Lab Sci. 2004;41(3):265-312. Review.

PMID:
15307634
8.

Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches.

Veveris-Lowe TL, Kruger SJ, Walsh T, Gardiner RA, Clements JA.

Semin Thromb Hemost. 2007 Feb;33(1):87-99. Review.

PMID:
17253195
9.

Human tissue kallikrein gene family: a rich source of novel disease biomarkers.

Diamandis EP, Yousef GM.

Expert Rev Mol Diagn. 2001 Jul;1(2):182-90. Review.

PMID:
11901813
10.

Human tissue kallikrein gene family: applications in cancer.

Obiezu CV, Diamandis EP.

Cancer Lett. 2005 Jun 16;224(1):1-22. Review.

PMID:
15911097
11.

Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?

Tan OL, Whitbread AK, Clements JA, Dong Y.

Biol Chem. 2006 Jun;387(6):697-705. Review.

PMID:
16800730
12.

Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.

Avgeris M, Mavridis K, Scorilas A.

Biol Chem. 2010 May;391(5):505-11. doi: 10.1515/BC.2010.056. Review.

PMID:
20302518
13.

Old genes and new genes: the evolution of the kallikrein locus.

Lundwall A.

Thromb Haemost. 2013 Sep;110(3):469-75. doi: 10.1160/TH12-11-0851. Epub 2013 Mar 28. Review.

PMID:
23571662
14.

The new human tissue kallikrein gene family: structure, function, and association to disease.

Yousef GM, Diamandis EP.

Endocr Rev. 2001 Apr;22(2):184-204. Review.

PMID:
11294823
15.

Genetic polymorphisms in the human tissue kallikrein (KLK) locus and their implication in various malignant and non-malignant diseases.

Batra J, O'Mara T, Patnala R, Lose F, Clements JA.

Biol Chem. 2012 Dec;393(12):1365-90. Review.

PMID:
23667899
16.

Evolution of the kallikrein gene family.

Murray SR, Chao J, Chao L.

Agents Actions Suppl. 1992;38 ( Pt 1):26-33. Review.

PMID:
1466278
17.

Tissue kallikreins: new players in normal and abnormal cell growth?

Yousef GM, Diamandis EP.

Thromb Haemost. 2003 Jul;90(1):7-16. Review.

PMID:
12876620
18.

Prostate-specific antigen: molecular forms and the human kallikrein gene family.

Lilja H.

Br J Urol. 1997 Mar;79 Suppl 1:44-8. Review. No abstract available.

PMID:
9088272
19.

Predictions for the future of kallikrein-related peptidases in molecular diagnostics.

Scorilas A, Mavridis K.

Expert Rev Mol Diagn. 2014 Jul;14(6):713-22. doi: 10.1586/14737159.2014.928207. Epub 2014 Jun 13. Review.

PMID:
24927162
20.

Tissue kallikrein inhibitors in mammals.

Chao J, Chai KX, Chao L.

Immunopharmacology. 1996 May;32(1-3):67-72. Review.

PMID:
8796269

Supplemental Content

Support Center